Applied Therapeutics, Inc. Total Liabilities
Applied Therapeutics, Inc. had Total Liabilities of $34.94 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-11-13
- 2025-09-30: Liabilities $34.94M.
- 2025-06-30: Liabilities $19.90M.
- 2025-03-31: Liabilities $20.24M.
- 2024-12-31: Liabilities $29.68M.
| Period end | Liabilities |
|---|---|
| 2025-09-30 | $34.94M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $19.90M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $20.24M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $29.68M 10-Q · filed 2025-11-13 |
| 2024-09-30 | $100.67M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $55.39M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $83.94M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $71.98M 10-K · filed 2025-04-15 |
| 2023-09-30 | $56.24M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $47.98M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $34.08M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $34.30M 10-K · filed 2024-03-06 |
| 2022-09-30 | $47.05M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $52.37M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $22.99M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $27.35M 10-K · filed 2023-03-23 |
| 2021-09-30 | $31.85M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $24.52M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $21.00M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $22.57M 10-K · filed 2022-03-10 |
| 2020-09-30 | $21.90M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $20.37M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $10.05M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $15.78M 10-K · filed 2021-03-18 |
| 2019-09-30 | $6.52M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $6.78M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $6.33M 10-Q · filed 2019-06-21 |
| 2018-12-31 | $4.43M 10-K · filed 2020-03-13 |